Are there safer alternatives to semaglutide while breastfeeding
Neuropsychiatric safety with liraglutide 30 mg for weight management: results from randomized controlled phase 2 and 3a trials
After that date, it may still be safe and effective, but there is not enough evidence to support beyond that timeframe
As patients lose weight and improve glycemic control, alterations in insulin sensitivity, leptin levels, and other metabolic hormones could potentially affect taste perception
Future directions and research gaps Although GLP-1 therapies have revolutionized obesity and diabetes management, important knowledge gaps remain in optimizing their long-term safety, tolerability, and body composition outcomes
Pharmacy coordination and transparent pricing